A novel prostate cancer immunotherapy using prostate-specific antigen peptides and skin test reagent as an adjuvant
Objectives: Our group developed the use of the Candida skin test reagent as an adjuvant of cell-mediated immunity in designing a human papillomavirus therapeutic vaccine. Here, this technology is being applied for designing a prostate cancer immunotherapy. Methods: Peptides based on the prostate-spe...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-09-01
|
Series: | SAGE Open Medicine |
Online Access: | https://doi.org/10.1177/2050312118800202 |